Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience.

MLA

Chen, Ping, et al. “Preliminary Study on the Efficacy of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Single-Centre Experience.” Frontiers in Endocrinology, vol. 14, Feb. 2023, p. 1044782. EBSCOhost, https://doi.org/10.3389/fendo.2023.1044782.

APA

Chen, P., Mao, M., Wang, C., Zhang, X., Zhao, X., Gao, Y., Luo, Y., & Zhou, Y. (2023). Preliminary study on the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A single-centre experience. Frontiers in Endocrinology, 14, 1044782. https://doi.org/10.3389/fendo.2023.1044782

Chicago

Chen, Ping, Min Mao, Chendan Wang, Xu Zhang, Xiaoyu Zhao, Yuanyuan Gao, Yankun Luo, and Yun Zhou. 2023. “Preliminary Study on the Efficacy of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Single-Centre Experience.” Frontiers in Endocrinology 14 (February): 1044782. doi:10.3389/fendo.2023.1044782.